Condition
Alzheimer's Disease Dementia clinical trials and research
Research outlook What's coming for Alzheimer's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Alzheimer's Disease Dementia clinical trials that are recruiting, at sites in 4 countries (most in China (1), United States (1), Brazil (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 4Countries
Newest Alzheimer's Disease Dementia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Alzheimer's disease dementia: see how blood biomarkers like p-Tau217 relate to behavioral symptoms | — | Tianjin, Tianjin Municipality | Recruiting | Oct 15, 2026 |
| Choose Myself (Before) Losing Myself | — | Cleveland, Ohio | Recruiting | Sep 29, 2026 |
| Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease | — | Rome | Recruiting | Sep 3, 2026 |
| Using Wearables to Find Clues About Mild Cognitive Impairment and Early Alzheimer’s | — | Manaus, Amazonas | Recruiting | Feb 5, 2026 |
All recruiting trials (4)
-
Alzheimer's disease dementia: see how blood biomarkers like p-Tau217 relate to behavioral symptoms
This is a prospective study that tests whether patients with probable Alzheimer's dementia who are negative for plasma p-Tau217 differ in behavioral symptoms from those who are positive, with follow-ups over 18 months.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Using Wearables to Find Clues About Mild Cognitive Impairment and Early Alzheimer’s
Researchers are testing whether wearable devices worn in daily life can help identify people 65 and older who might have mild cognitive impairment or early Alzheimer’s disease.
Related topics
Quick answers
How many Alzheimer's Disease Dementia clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), United States (1 trial), Brazil (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.